Henry Schein, Inc.

HSIC

$90.86

+0.52%

N/A+$0.47

Healthcare

Medical - Distribution

NASDAQ

Active Trading

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to ...

CEO Profile of HSIC

Frederick M. Lowery

Henry Schein, Inc.

Tenure 0yKey-man risk: Low

Frederick M. Lowery takes over a robust company with a dominant market position. The investment focus remains on his ability to drive growth through technological integration and operational efficiency while...

Key Risk

•Integration of new leadership vision

•Market competition in health care distribution

Key Tailwind

•Stable company structure and strong balance sheet

•Long-term trends in digital dental/medical health care

Frederick M. Lowery

Henry Schein, Inc. (HSIC) · NASDAQ

AmericanTenure 0 yearsNon-founder CEOKey-man risk: Low

Origin Story

Frederick M. Lowery was appointed CEO in early 2026, succeeding long-time leader Stanley M. Bergman to spearhead the company's next phase of growth.

Early Life: Lowery joined Henry Schein following a career in executive leadership, most recently serving in senior operational and strategic roles.

First Break: Appointment as CEO of Henry Schein, Inc. in March 2026 following an executive search process to find a successor for the 35-year veteran Stanley M. Bergman.

Path to CEO: Lowery was selected by the board to modernize and scale the business, bringing external perspective to a company traditionally defined by its long-serving founder-like leader.

Frederick M. Lowery transitioned into the CEO role at Henry Schein in March 2026. His appointment marked the end of the 35-year tenure of Stanley M. Bergman, who transformed the company from a small distributor into a global Fortune 500 health care powerhouse. Lowery’s mandate is to build upon this legacy while adapting to the increasingly digital and complex landscape of global health care supply chain and technology solutions.

new ceoexecutive transition

Investment Take

Key Tailwinds

Stable company structure and strong balance sheet

Long-term trends in digital dental/medical health care

Key Risks

Integration of new leadership vision

Market competition in health care distribution

Career History

Lowery enters the CEO role after a career marked by senior executive operational roles.

Henry Schein, Inc.

Initiative: CEO

Period: 2026–Present

Event: Succeeding long-time leader Stanley M. Bergman.

executive leadership

Company Performance

Lowery has assumed leadership during a period of transition following decades of expansion under Bergman.

Revenue: Historically grew from $225M in 1989 to ~$13B under Bergman; Lowery is now focused on maintaining this scale.

Profitability: Stable margin profile; transition focuses on margin expansion and technological integration.

Stock: The stock is currently adjusting to the new leadership and strategic changes initiated in 2026.

•Successful CEO transition announced January 2026

turnaroundpost-founder transition

Management Ability

Lowery is tasked with leading a complex, global organization through a modern operational refresh.

Style: Strategic and operations-focused leader.

As the new CEO, Lowery is emphasizing organizational efficiency and the integration of technology into the company’s massive distribution network. His ability to lead a deeply ingrained corporate culture established by his predecessor is central to his early management strategy.

operational focusstrategic leadership

Capital Allocation

The company maintains a focus on disciplined capital allocation and strategic M&A.

Consistent focus on debt management and internal investment in core distribution capabilities.

The company continues its legacy of disciplined capital allocation, recently bolstered by strategic partnerships such as the 2025 KKR investment, which provided capital to support long-term value creation.

capital disciplinem&a

Fundraising & Financing

The company has a well-established credit profile and investor base.

Strategic equity investment · Not explicitly disclosed in snippet: KKR investment providing capital for future growth (2025)

Dilution: Moderate, with recent private equity involvement.

Investor confidence remains high due to the company's long-term financial track record and the orderly nature of the recent leadership handoff.

investor relations

Governance & Control

The company has maintained a professional governance structure with high board oversight.

Dual-class Shares: No

Share Class Detail: Single-class share structure.

Governance is characterized by a strong, independent board. The transition of leadership included updates to board composition to ensure independent oversight following Bergman's retirement.

governanceboard independence

Health & Succession

Succession is finalized, mitigating key-man risk associated with the previous CEO.

Health Status: No public concerns.

Succession Plan Disclosed: Yes

Key-man Risk: Low

Succession was successfully completed in 2026.

succession planning

R&D & Tech Vision

Technological innovation remains a key pillar of growth through the 'Henry Schein One' division.

Significant investment continues in digital dental platforms and software solutions.

Focuses on digitizing the dental and medical office workflow.

The R&D and technology strategy is heavily tied to the company's software and technology services, aiming to become the indispensable operating system for health care practitioners.

technologyinnovation

Talent Recruitment

Talent retention and attraction are prioritized through a strong company culture.

High-quality, long-tenured leadership team remains in place.

Retention: Strong historical retention, now tested by leadership transition.

Maintaining the 'Team Schein' culture during the CEO transition is a core management priority to ensure key talent remains engaged.

talent managementculture

Strengths

Deep operational knowledge of the global health care supply chain.

Operational continuity: Leveraging a long-established, stable organizational foundation.

operational excellence

Weaknesses & Failures

Lowery must prove his ability to replicate the growth achieved during the company's long initial expansion phase.

Transition risk

Managing the departure of a 35-year veteran leader.

Example: Ongoing post-succession execution.

succession risk

Marketing & Brand

Focuses on maintaining the brand's position as the world's largest provider of health care products and services.

High brand equity built over decades as a reliable partner to dental and medical practitioners.

The marketing strategy continues to center on 'Team Schein,' emphasizing partnership and community support for health care professionals, a brand pillar established during the Bergman era.

brand equityhealth care services

PR & Communication

Lowery’s PR persona is currently being established as he takes on the public face of the company.

Media Reputation: Positive; media focus is currently on the orderly succession.

The succession has been communicated as a stable, long-planned transition. Lowery has stepped into a high-visibility role, with early public engagements focusing on stability and continuity.

public relationsstability

Supply Chain of HSIC

Upstream / Downstream / Proxies

Upstream

3M CompanyNYSE:MMM Dentsply Sirona Inc.NASDAQ:XRAY Danaher CorporationNYSE:DHR Envista Holdings CorporationNYSE:NVST Colgate-Palmolive CompanyNYSE:CL Procter & Gamble CompanyNYSE:PG Zimmer Biomet Holdings, Inc.NYSE:ZBHStraumann Holding AGSWX:STMNAlign Technology, Inc.NASDAQ:ALGNGC CorporationTSE:4971Ivoclar Vivadent AGMidmark CorporationA-dec Inc.Biolase, Inc.NASDAQ:BIOL Sirona (now part of Dentsply Sirona - historical)NASDAQ:XRAYCarestream Dental LLCPatterson Companies, Inc.NASDAQ:PDCO Zoetis Inc.NYSE:ZTSBoehringer Ingelheim VetmedicaElanco Animal Health Inc.NYSE:ELAN Becton, Dickinson and CompanyNYSE:BDX Cardinal Health, Inc.NYSE:CAH Owens & Minor, Inc.NYSE:OMI Kavo (now part of Danaher - KaVo Kerr)NYSE:DHR Corning IncorporatedNYSE:GLWBASF SEXETRA:BASMitsubishi Chemical GroupTSE:4188DSM-Firmenich AGSWX:DSFIRIntel CorporationNASDAQ:INTC Microsoft CorporationNASDAQ:MSFT Amazon Web Services (Amazon.com)NASDAQ:AMZN

Downstream

Heartland Dental LLCAspen Dental Management, Inc.Pacific Dental Services LLCInterDent Service Corporation (Gentle Dental)Smile Brands Inc.U.S. Department of Veterans Affairs (VHA)U.S. Department of Defense (DHA/DLA)Indian Health Service (IHS)Independent Dental DealersInternet Brands (KKR-backed)Dental School & Academic InstitutionsVCA Animal Hospitals (VCA, Inc. / Mars Petcare)Banfield Pet Hospital (Mars Petcare)

Proxies

Patterson Companies, Inc.NASDAQ:PDCO McKesson CorporationNYSE:MCK Cardinal Health, Inc.NYSE:CAH Owens & Minor, Inc.NYSE:OMI Dentsply Sirona Inc.NASDAQ:XRAY

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer